# Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children

> **NCT02836431** · PHASE1 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 18 (actual)

## Conditions studied

- Heart Disease

## Interventions

- **DRUG:** Dexmedetomidine 1mcg/kg Intranasal
- **DRUG:** Dexmedetomidine 2mcg/kg Intranasal
- **DRUG:** Dexmedetomidine 1mcg Intravenous

## Key facts

- **NCT ID:** NCT02836431
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2017-12
- **Final completion:** 2018-04
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2018-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02836431

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02836431, "Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02836431. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*